Outcomes of surgical septal myectomy for obstructive hypertrophic cardiomyopathy after previous septal reduction therapy
The Journal of Thoracic and Cardiovascular Surgery · 2025
DOI: 10.1016/j.jtcvs.2024.05.002 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2025. Verfasst von Younus Qamar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Heart Septum, Ventricular Outflow Obstruction, Cardiac Surgical Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To compare early and late outcomes of septal myectomy in patients with obstructive hypertrophic cardiomyopathy who presented with residual or recurrent left ventricular outflow tract (LVOT) obstruction after previous septal-reduction therapy (SRT). METHODS: From January 1989 to March 2022, 145 patients underwent reintervention by septal myectomy for residual LVOT obstruction after previous SRT; 72 patients had previous alcohol septal ablation (ASA) and 73 had previous surgical septal myectomy. Baseline patient characteristics, echocardiographic parameters, and surgical outcomes were compared between these 2 groups. RESULTS: Patients who had previous ASA were more likely to be male (50.0% vs 30.1%; P = .015), be older (median age 57.5 years vs 48.3 years; P < .001), and have a greater body mass index (32.7 kg/m2 vs 30.0 kg/m2; P = .011). After repeat SRT by septal myectomy, there was no significant difference in the incidence of postoperative complete heart block, necessitating permanent pacemaker, between the 2 groups (8.3% vs 2.7%; P = .151). One (0.7%) patient died within 30 days of surgery. Over a median follow-up of 7.5 years (interquartile range, 3.0-13.8), there were 20 deaths. Kaplan-Meier 5-, 10-, and 15-year survival rates were 100%, 91%, and 76% for the previous septal myectomy group, and 93%, 81%, and 64% for the previous ASA group (P = .207). CONCLUSIONS: Septal myectomy for residual or recurrent LVOT obstruction in patients who had previous ASA is safe, with an acceptably low rate of postoperative complete heart block. Surgical outcomes and late survival rates in patients with complete heart block ASA were satisfactory and comparable with patients who underwent repeat myectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
- Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn. Electronic address: schaff@mayo.edu.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minn.
Zitieren
APA
Qamar, Y., Schaff, H. V., Castro-Varela, A., Cui, H., Dearani, J. A., Geske, J. B., Eleid, M. F., Lee, A. T., Lahr, B., & Ommen, S. R. (2025). Outcomes of surgical septal myectomy for obstructive hypertrophic cardiomyopathy after previous septal reduction therapy. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2024.05.002
Vancouver
Qamar Y, Schaff HV, Castro-Varela A, Cui H, Dearani JA, Geske JB, et al. Outcomes of surgical septal myectomy for obstructive hypertrophic cardiomyopathy after previous septal reduction therapy. The Journal of Thoracic and Cardiovascular Surgery. 2025. doi:10.1016/j.jtcvs.2024.05.002
BibTeX
@article{Qamar2025,
author = {Qamar, Younus and Schaff, Hartzell V and Castro-Varela, Alejandra and Cui, Hao and Dearani, Joseph A and Geske, Jeffrey B and Eleid, Mackram F and Lee, Alexander T and Lahr, Brian and Ommen, Steve R},
title = {Outcomes of surgical septal myectomy for obstructive hypertrophic cardiomyopathy after previous septal reduction therapy},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2025},
doi = {10.1016/j.jtcvs.2024.05.002}
}
EUVIMED